RIGL (RIGL) revenue breakdown
By product, Gross product sales is the largest at 83% of fiscal 2025 revenue, growing 45% a year over 2 years.
Revenue by product
Fiscal years, as RIGL reports them in its 10-K filings; fiscal 2025 total $372M.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross product sales | — | — | — | — | — | — | — | $147M | $210M | $310M | 83% |
| Release Of Share Cost Liability | — | — | — | — | — | — | — | — | — | $40M | 11% |
| Delivery of drug supplies, royalty and others | — | — | — | — | — | — | — | $11M | $20M | $19M | 5% |
| Milestone revenue | — | — | — | — | — | — | — | $75,000 | — | $3M | 1% |
| Government contracts | — | — | — | — | — | — | — | $1M | — | $265,000 | 0% |
| License revenue | — | — | — | — | — | — | — | — | $14M | — | — |
| Product sales, net | — | — | $14M | $44M | $62M | $63M | $77M | — | — | — | — |
| Contract revenues from collaborations | — | — | $31M | $16M | $47M | $76M | $39M | — | — | — | — |
| Development milestones | $20M | — | — | — | — | — | — | — | — | — | — |
| Government contracts | — | — | — | — | — | $10M | $4M | — | — | — | — |
| Development milestones | — | $4M | — | — | — | — | — | — | — | — | — |
| Research and development services | $290,000 | — | — | — | — | — | — | — | — | — | — |
| License revenues | — | $250,000 | — | — | — | — | — | — | — | — | — |
| Discounts and allowances | — | — | — | — | — | — | — | -$43M | -$65M | -$78M | -21% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for RIGL.
Open RIGL in InvestinglyQuestions
Where does RIGL make its money?
In fiscal 2025, by product: Gross product sales $310M, Release Of Share Cost Liability $40M, Delivery of drug supplies, royalty and others $19M, Milestone revenue $3M, Government contracts $265,000.
From RIGL's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.